AI Article Synopsis

  • The study investigates how different cell-permeating peptides influence the distribution of Fab fragments in rats.
  • The Fab fragments were marked using radioiodine and administered alongside various cell-permeating peptides, leading to varied concentrations in organs like the spleen and liver over time.
  • Results show that the choice of cell-penetrating peptide can significantly affect both the distribution and retention patterns of the Fab-peptide complexes in the body, which could inform future antibody drug design.

Article Abstract

The peptides comprising the sequence of HIV-1 Tat protein (positions 48-60), Antennapedia (positions 43-58), and HIV-1 Rev protein (positions 34-50) are known to be cell-permeating. In this study, we examined how the distribution of Fab fragments in rats is affected by conjugation with these peptides. Fab fragment was iodinated by a chloramine-T method and then chemically conjugated with cell-permeating peptide. The complex of 125I-Fab and cell-permeating peptide was administered to male rats intravenously at a dose of 1 mg/kg, and whole-body autoradiography was performed at 4 and 24 h after administration. The patterns of distribution of 125I-Fab exhibited remarkable variation depending on the cell-permeating peptide used. In particular, at 4 h, high concentrations of radioactivity were observed in the spleen, adrenal gland, renal medulla, and liver with Rev peptide-Fab complex, in the liver and spleen with Tat peptide-Fab complex, and in the spleen, adrenal gland, and liver with Antennapedia peptide-Fab complex. Even at 24 h, high concentrations of radioactivity were still observed in the spleen and renal medulla of rat with Rev peptide-Fab complex, and in the spleen and renal cortex of rat with Antennapedia peptide-Fab complex. These findings demonstrate that the patterns of distribution of peptide-125I-Fab complexes can be modulated by selection of cell-penetrating peptides. Moreover, the patterns of retention of peptide-125I-Fab complexes in internal organs also differed at 24 h after administration. These findings provide valuable information for the development of novel antibody pharmaceuticals and therapeutic systems.

Download full-text PDF

Source
http://dx.doi.org/10.1021/bc050258kDOI Listing

Publication Analysis

Top Keywords

peptide-fab complex
20
cell-permeating peptide
16
fab fragment
8
protein positions
8
patterns distribution
8
high concentrations
8
concentrations radioactivity
8
radioactivity observed
8
observed spleen
8
spleen adrenal
8

Similar Publications

Dissociation of the Dimer of the Intrinsically Disordered Domain of RNase Y upon Antibody Binding.

Biophys J

December 2018

Laboratoire de Chimie des Processus Biologiques, UMR 8229 CNRS, Collège de France, Université Pierre et Marie Curie, Paris CEDEX 05, France. Electronic address:

Although RNase Y acts as the key enzyme initiating messenger RNA decay in Bacillus subtilis and likely in many other Gram-positive bacteria, its three-dimensional structure remains unknown. An antibody belonging to the rare immunoglobulin G (IgG) 2b λx isotype was raised against a 12-residue conserved peptide from the N-terminal noncatalytic domain of B. subtilis RNase Y (BsRNaseY) that is predicted to be intrinsically disordered.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how different cell-permeating peptides influence the distribution of Fab fragments in rats.
  • The Fab fragments were marked using radioiodine and administered alongside various cell-permeating peptides, leading to varied concentrations in organs like the spleen and liver over time.
  • Results show that the choice of cell-penetrating peptide can significantly affect both the distribution and retention patterns of the Fab-peptide complexes in the body, which could inform future antibody drug design.
View Article and Find Full Text PDF

Disulphide dimerised peptide creates a crystal contact in an anti-peptide antibody.

Acta Crystallogr D Biol Crystallogr

October 2002

CEA, Département d'Ingénierie des Protéines (DIEP), CE Saclay, 91191 Gif-sur-Yvette, France.

Although many Fab derived from human and murine antibodies have been crystallized, several such fragments, including anti-peptide Fab 4 x 11, remain problematic for crystallisation. Diffracting crystals have been obtained for this Fab only in complex with a cysteine containing peptide CGGIRGERA. The IRGERA portion contained in the C-terminus of histone H3 is recognised by the monoclonal antibody and the CGG portion is an essential spacer.

View Article and Find Full Text PDF

Crystal structure of an Fab fragment in complex with a meningococcal serosubtype antigen and a protein G domain.

J Mol Biol

October 1999

Department of Biomolecular Sciences, UMIST, Manchester, M60 1QD, UK.

Many pathogens present highly variable surface proteins to their host as a means of evading immune responses. The structure of a peptide antigen corresponding to the subtype P1.7 variant of the porin PorA from the human pathogen Neisseria meningitidis was determined by solution of the X-ray crystal structure of the ternary complex of the peptide (ANGGASGQVK) in complex with a Fab fragment and a domain from streptococcal protein G to 1.

View Article and Find Full Text PDF

The principal neutralizing determinant (PND) of human immunodeficiency virus type 1 (HIV-1) is located in the third hypervariable region (V3) of the virus envelope glycoprotein gp120. The conformation of a V3 peptide of HIV-1IIIB bound to the Fab fragment of an anti-gp120 HIV neutralizing antibody, 0.5beta, was studied by 1H NMR spectroscopy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!